1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Breast Neoplasm Malignant Female: new trials by email Literature Review of Breast Neoplasm Malignant Female trials Research Report on Breast Neoplasm Malignant Female
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer Omission of local therapies - Breast Neoplasm Malignant Female | Phase 2 | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 152 | 2025-07-25 | 2025-09-15 |
| Study of the Impact of DPD Activity on the Efficacy of Capecitabine DPD activity assessment, Capecitabine - Breast Neoplasm Malignant Female | Phase 2 | Active not recruiting | Centre Antoine Lacassagne | 155 | 2020-07-20 | 2026-06-02 |
| PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells - Advanced Breast Cancer, Breast Neoplasm Malignant Female | Phase 1 / Phase 2 | Completed | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 15 | 2019-05-17 | 2023-04-13 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Capecitabine (1) · Immunophenotyping (1)
Centre Antoine Lacassagne (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (1) · France (1) · Italy (1) · Monaco (1)
Erwei Song, MD, PhD (1) · Massimiliano Gennaro, MD (1)